Performance of the 2017 EULAR/ACR Classification Criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a scoping review
Authors' conclusion
The results of this review suggest that a revision of the EULAR/ACR criteria is warranted.
Study context
- Population
- Studies on the 2017 EULAR/ACR classification criteria for adult/juvenile idiopathic inflammatory myopathies (IIM) published between October 2017 and January 202319 articles and 13 abstracts
- Outcome
- Performance characteristics of the 2017 EULAR/ACR classification criteria in various cohorts and IIM subtypes
Methodological detailssystematic search of Medline (via PubMed), CINAHL and conference abstract archives, independent search by three investigators, Undertaken as part of a large international project to revise the EULAR/ACR criteria
- Systematic search of Medline (via PubMed), CINAHL and conference abstract archives
- Independent search by three investigators
- Undertaken as part of a large international project to revise the EULAR/ACR criteria
Main finding
As reported in the abstract
Performance of the 2017 EULAR/ACR criteria for IIM
- Overall good performance characteristics of the EULAR/ACR criteria for IIM
- Deficiencies: lack of inclusion of certain IIM subtypes (IMNM, amyopathic DM, ASyS, overlap myositis)
- Published modifications that may improve performance for classification of IIM subtypes were summarised
Original publication
Performance of the 2017 EULAR/ACR Classification Criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a scoping review. Clin Exp Rheumatol. Published 30 October 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →